Attention AACR Annual Meeting 2018 Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 73 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 70 71 72 73 presentations: 1 to 25 of 1806
Autophagy overview and roles in tumor cell death
Andrew M. Thorburn
Univ. of Colorado Denver, Aurora, CO, United States
from AACR Annual Meeting 2018 on April 14, 2018 10:15 AM-12:15 PM
Autophagy in tumor progression to metastasis
Kay F Macleod
Univ. of Chicago Ben May Dept. for Cancer Res., Chicago, IL, United States
from AACR Annual Meeting 2018 on April 14, 2018 10:15 AM-12:15 PM
Autophagy in the tumor immune response
Lorenzo Galluzzi
Weill Cornell Medical College, New York, NY, United States
from AACR Annual Meeting 2018 on April 14, 2018 10:15 AM-12:15 PM
Targeting autophagy in the clinic and next generation autophagy drugs
Ravi K. Amaravadi
Univ. of Pennsylvania, Philadelphia, PA, United States
from AACR Annual Meeting 2018 on April 14, 2018 10:15 AM-12:15 PM
Introduction
Elaine R Mardis
Nationwide Children's Hospital, Columbus, OH, United States
from AACR Annual Meeting 2018 on April 15, 2018 9:45 AM-12:15 PM
Liquid biopsy: Novel technologies and clinical applications
Klaus Pantel
University Medical Ctr. Hamburg, Hamburg, Germany
from AACR Annual Meeting 2018 on April 15, 2018 9:45 AM-12:15 PM
Immune checkpoint therapy: From CTLA-4 to PD-1/PD-L1 and beyond
Padmanee Sharma
UT MD Anderson Cancer Ctr., Houston, TX, United States
from AACR Annual Meeting 2018 on April 15, 2018 9:45 AM-12:15 PM
Pembrolizumab versus placebo after complete resection of high-risk stage III melanoma: Efficacy and safety results from the EORTC 1325-MG/Keynote 054 double-blinded phase III trial
Alexander M Eggermont
Gustave Roussy Cancer Campus Grand Paris & University Paris-Saclay, Villejuif, France
from AACR Annual Meeting 2018 on April 15, 2018 9:45 AM-12:15 PM
Discussant
Antoni Ribas
UCLA Medical Ctr., Los Angeles, CA, United States
from AACR Annual Meeting 2018 on April 15, 2018 9:45 AM-12:15 PM
Mobilizing immunity against ovarian cancer
George Coukos
Ludwig Center for Cancer Research- University of Lausanne, Lausanne, Switzerland
from AACR Annual Meeting 2018 on April 15, 2018 9:45 AM-12:15 PM
Cancer chromosome evolution in metastases, immune evasion, adaptation and clinical outcome: Insights from the TRACERx studies
Charles Swanton
The Francis Crick Institute and UCL Cancer Institute, London, United Kingdom
from AACR Annual Meeting 2018 on April 15, 2018 9:45 AM-12:15 PM
Opportunities/Challenges for the Future
Elaine R Mardis
Nationwide Children's Hospital, Columbus, OH, United States
from AACR Annual Meeting 2018 on April 15, 2018 9:45 AM-12:15 PM
Next generation humanized mice in cancer research
Leonard D Shultz
The Jackson Laboratory Cancer Ctr., Bar Harbor, ME, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Targeting the innate immune response in models of leukemia and lymphoma
David M Weinstock
Dana-Farber Cancer Inst., Boston, MA, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Understanding clonal complexity of human hematologic malignancies by single-cell genomics and PDX modeling
Fumihiko Ishikawa
RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Integrated Genomics for PDX
Carol J Bult
The Jackson Laboratory, Bar Harbor, ME, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Angiogenesis revisited: Role and (therapeutic) implications of endothelial metabolism
Peter Carmeliet
VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Reprogram the tumor microenvironment by interrupting glutamine metabolism
Ping-Chih Ho
Univ. of Lausanne, Epalinges, Switzerland
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Autophagy and cellular metabolism in cancer progression and treatment
Eileen P White
Rutgers-The Cancer Inst. of New Jersey, New Brunswick, NJ, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Invited Speaker
Navdeep S Chandel
Northwestern Univ., Chicago, IL, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Intraoperative tumor grading through rapid lipidomic profiling with picosecond infra red laser mass spectrometry (PIRL-MS)
Arash Zarrine-Afsar
Univ. of Toronto, Toronto, ON, Canada
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Application of mass spectrometry in CANscript: A patient-derived ex-vivo platform for biomarker discovery in cancer
Aaron J Goldman
Harvard Medical School, Cambridge, MA, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Urinary prostaglandin E2 metabolites as biomarkers in cancer
Ginger L Milne
Vanderbilt University Medical Center, Nashville, TN, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Recent advances in mass spectrometry-based oncology biomarker discovery
Ahmed M Aman
Ontario Inst. for Cancer Research, Toronto, ON, Canada
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Understanding and targeting RNA splicing factor mutations in cancer
Omar Abdel-Wahab
Mem. Sloan Kettering Cancer Ctr., New York, NY, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
<< first | < prev page: of 73 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 70 71 72 73 presentations: 1 to 25 of 1806